Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.

Antonio Santo; Giovenzio Genestreti; Alberto Terzi; Paolo Azzoni; Teodoro Sava; Pietro Manno; Annamaria Molino; Cristian Pattaro; Rocco Micciolo; Gian Luigi Cetto

doi:10.1016/j.lungcan.2006.05.013

Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.

Identifier:nobleid.org/w1/20260515/C7EB3090

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C7EB3090.svg?ark=w1%2F20260515%2FC7EB3090)](https://nobleid.org/work/w1/20260515/C7EB3090)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.

Identifier:nobleid.org/w1/20260515/C7EB3090

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C7EB3090.svg?ark=w1%2F20260515%2FC7EB3090)](https://nobleid.org/work/w1/20260515/C7EB3090)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work